The ALS Treatment and Research Center, a clinical practice of the Department of Neurology at UCSF and an ALS Association-certified Center of Excellence, is expanding its support for the community of people facing amyotrophic lateral sclerosis.
April 03, 2014
April 03, 2014
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
February 26, 2014
Researchers worldwide will now have access to genetic data linked to medical information on a diverse group of more than 78,000 people, enabling investigations into many diseases and conditions.
February 25, 2014
UCSF and Walgreens have opened a unique Walgreens store that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively.
February 21, 2014
Samsung Electronics Co., Ltd., and UC San Francisco have announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.
January 13, 2014
Geneticists from Ohio, California and Japan used stem cells to correct a defective “ring chromosome” with a normal chromosome. Such therapy has the promise to correct chromosome abnormalities that give rise to birth defects, mental disabilities and growth limitations.
January 09, 2014
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
December 09, 2013
Hear 26 teams of physicians, scientists and students present what they learned about moving their ideas from the lab or clinic to the marketplace in the nation’s first course on applying the Lean Launchpad model of entrepreneurship to the bioscience, medical devices and digital health sectors.
August 19, 2013
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
June 03, 2013
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center today announced the formation of the Oncology Innovation Alliance (OIA), a public-private partnership focusing on the discovery and development of novel therapies and their potential role in treating various types of hematologic cancers and solid tumors.